CTA FOCUS announces the opening of its new subsidiary in Kiev, Ukraine
Bucharest – Romania, 16th of July 2018
Clinical Trial Agreements FOCUS (CTA FOCUS), a Romanian based company with global clinical research services, has announced today the opening of its new subsidiary in Kiev, Ukraine.
In addition to its current headquarters, located in Bucharest, Romania and Malaga, Spain, the company will have, as of July 1st, a new headquarter in one of Europe’s most promising capitals.
The Ukrainian division, registered at 17, Savrasova Street, 03110 – Kiev, Ukraine, will be focused mainly on clinical trials negotiation, its secondary focus being on site payments.
The Ukrainian market will support CTA FOCUS’s strong growth on the Eastern European market, thanks to its highly skilled investigators, robust clinical infrastructure, faster time to recruit patients, customized cost efficiencies.
Ukraine is Europe’s largest country. It offers an easily accessible, modern-treatment-naïve population, eager and well-trained investigators, practices that conform to international quality standards and a legislation aligned with EU regulations. The number of physicians is also high at 35.2 per 10,000 people.
The company is very glad to announce this new opportunity and is confident that, within its international know-how and strategic alliances with international companies in US and Asia, it will improve the lives of many Ukrainian patients in the forthcoming years.
About CTA Focus
CTA Focus is an international contracting company with significant experience in negotiating clinical contracts in over 57 countries through EMEA, North and South America. Led by professionals with vast hands-on experience in both CRO and Clinical Sponsor’s legal departments.
With its global reach, CTA Focus is the best business solution for both pharmaceutical companies and CRO’s facing challenges in contract and budget negotiations.
For more details, please contact: CTA Focus: Elisa Toma /Email elisa.toma@ctafocus.com